3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
29
OTHER_GOV
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Polycystic Ovary Syndrome
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Obesity
2
Endometrial Hyperplasia
2
Triple Negative Breast Neoplasms
1
Prostatic Neoplasms
1
Metformin
1
Metabolic Diseases
1
Ketosis
1
Insulin Resistance
1
Infertility
1
Glioma
1
Glioblastoma
1
Endometrial Neoplasms
1
Diabetes, Gestational
1
Communicable Diseases
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
3
Zoledronic Acid
3
enzalutamide
2
darolutamide
2
Magnetic Resonance Spectroscopy
2
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
2
Androgen Antagonists
2
Abiraterone Acetate
2
apalutamide
1
abiraterone
1
Watchful Waiting
1
Videotape Recording
1
Urination
1
Ultrasound, High-Intensity Focused, Transrectal
1
Transurethral Resection of Prostate
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Single Photon Emission Computed Tomography Computed Tomography
1
Rehabilitation
1
Radiotherapy
1
Radiosurgery
1
Prednisone
1
Prednisolone
1
Positron Emission Tomography Computed Tomography
1
Multiparametric Magnetic Resonance Imaging
1
Metformin
1
Magnetic Resonance Imaging
1
Finasteride
1
Everolimus
1
Dutasteride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Prostatic Neoplasms
×
Metformin
×
Clear all
NCT00268476
2023-04-18
STAMPEDE
Medical Research Council
Phase 2/3
Active not recruiting
11,992 enrolled